To find the “optimal” number of biopsy fragments to predict HER2 status in gastric operation specimens, the actual difference value of HER2 scores identified between the paired biopsy and operation specimens was calculated among a large number of gastric cancer cases. The gene discussed is ERBB2; the disease is gastric cancer.